Patents by Inventor Carl Baxter
Carl Baxter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11958380Abstract: Dynamic allocation of power modules for charging electric vehicles is described herein. The charging system includes multiple dispensers that each include one or more power modules that can supply power to any one of the dispensers at a time. A dispenser includes a first power bus that is switchably connected to one or more local power modules and switchably connected to one or more power modules located remotely in another dispenser. The one or more local power modules are switchably connected to a second power bus in the other dispenser. The dispenser includes a control unit that is to cause the local power modules and the remote power modules to switchably connect and disconnect from the first power bus to dynamically allocate the power modules between the dispenser and the other dispenser.Type: GrantFiled: October 4, 2021Date of Patent: April 16, 2024Assignee: ChargePoint, Inc.Inventors: Richard J. Quattrini, Jr., Peter Vaughan, David Baxter, Carl F. Hagenmaier, Jr., Patrick Kien Tran, Craig T. Matsuno, Gary A. Eldridge, Pasquale Romano
-
Publication number: 20240083298Abstract: Dynamic allocation of power modules for charging electric vehicles is described herein. The charging system includes multiple dispensers that each include one or more power modules that can supply power to any one of the dispensers at a time. A dispenser includes a first power bus that is switchably connected to one or more local power modules and switchably connected to one or more power modules located remotely in another dispenser. The one or more local power modules are switchably connected to a second power bus in the other dispenser. The dispenser includes a control unit that is to cause the local power modules and the remote power modules to switchably connect and disconnect from the first power bus to dynamically allocate the power modules between the dispenser and the other dispenser.Type: ApplicationFiled: November 13, 2023Publication date: March 14, 2024Inventors: Richard J. Quattrini, JR., Peter Vaughan, David Baxter, Carl F. Hagenmaier, JR., Patrick Kien Tran, Craig T. Matsuno, Gary A. Eldridge, Pasquale Romano
-
Patent number: 11401266Abstract: The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.Type: GrantFiled: July 16, 2015Date of Patent: August 2, 2022Assignee: Merck Sharp & Dohme (UK) Ltd.Inventors: Carl A. Baxter, Faye Sheen
-
Publication number: 20210309650Abstract: The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.Type: ApplicationFiled: July 16, 2015Publication date: October 7, 2021Applicants: Merck Sharp & Dohme Corp., Merck Sharp & Dohme Ltd.Inventors: Carl A. Baxter, Edward Cleator, Faye Sheen, Shane W. Krska, Gavin Stewart, Neil Strotman, Debra J. Wallace, Timothy Wright
-
Patent number: 10308633Abstract: This invention provides novel processes for the preparation of compounds such as 3-[(1S,2S)-2-hydroxycyclohexyl]-6-[(6-methylpyridin-3-yl)methyl]benzo[h]-quinazolin-4(3H)-one, salts and derivatives thereof. The compounds synthesized by the processes of the invention are useful for treating Alzheimer's disease and other diseases (e.g., cognitive impairment, schizophrenia, pain disorders, and sleep disorders) mediated by the muscarinic M1 receptor.Type: GrantFiled: September 26, 2016Date of Patent: June 4, 2019Assignees: Merck Sharp & Dohme Corp., Merck Sharp & Dohme LimitedInventors: Qinghao Chen, Shane W. Krska, Lushi Tan, Peter E. Maligres, Jeremy Scott, Carl Baxter, Gavin William Stewart, Andrew Gibb
-
Publication number: 20180265493Abstract: This invention provides novel processes for the preparation of compounds such as 3-[(1S,2S)-2-hydroxycyclohexyl]-6-[(6-methylpyridin-3-yl)methyl]benzo[h]-quinazolin-4(3H)-one, salts and derivatives thereof. The compounds synthesized by the processes of the invention are useful for treating Alzheimer's disease and other diseases (e.g., cognitive impairment, schizophrenia, pain disorders, and sleep disorders) mediated by the muscarinic M1 receptor.Type: ApplicationFiled: September 26, 2016Publication date: September 20, 2018Applicants: Merck Sharp & Dohme Corp., Merck Sharp & Dohme Limited.Inventors: Qinghao Chen, Shane W. Krska, Lushi Tan, Peter E. Maligres, Jeremy Scott, Carl Baxter, Gavin William Stewart, Andrew Gibb
-
Patent number: 9108959Abstract: The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.Type: GrantFiled: February 27, 2012Date of Patent: August 18, 2015Assignees: Merck Sharp & Dohme Corp., Merck Sharp & Dohme LimitedInventors: Carl A. Baxter, Edward Cleator, Faye Sheen, Shane W. Krska, Gavin Stewart, Neil Strotman, Debra J. Wallace, Timothy Wright
-
Patent number: 9073825Abstract: A first aspect of the present invention describes a compound selected from group consisting of: wherein R is either H, C(O)RA, or C(O)NHCH(X)COOH; provided that X is a C2-C6 alkyl, or a C3-C8 cycloalkyl and RA is a C1-6 alkyl or aryl; These compounds are used to make Compound AType: GrantFiled: August 16, 2012Date of Patent: July 7, 2015Assignees: Merck Sharp & Dohme Limited, Merck Sharp & Dohme Corp.Inventors: Nobuyoshi Yasuda, Jeffrey T. Kuethe, Guy Humphrey, Gregory L. Beutner, Yong-Li Zhong, Edward Cleator, Carl Baxter
-
Publication number: 20140243519Abstract: The present invention includes compounds useful as intermediates in the preparation of macrolactams, methods for preparing the intermediates, and methods for preparing macrolactams. One use of the methods and intermediates described herein is in the production of macrolactam compounds able to inhibit HCV NS3 protease activity.Type: ApplicationFiled: August 16, 2012Publication date: August 28, 2014Inventors: Nobuyoshi Yasuda, Jeffrey T. Kuethe, Guy Humphrey, Gregory L. Beutner, Yong-Li Zhong, Edward Cleator, Carl Baxter
-
Publication number: 20130331379Abstract: The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.Type: ApplicationFiled: February 27, 2012Publication date: December 12, 2013Inventors: Carl A. Baxter, Edward Cleator, Faye Sheen, Shane W. Krska, Gavin Stewart, Neil Strotman, Debra J. Wallace, Timothy Wright
-
Publication number: 20050082056Abstract: A centralizer system is provided for use in a marine riser system with an insulated pipe, which may be a titanium stress joint. The centralizer system utilizes one or more centralizers mounted such that insulation material is provided in an annulus between the one or more centralizers and the stress joint. A clamp is utilized to axially affix either one centralizer or multiple centralizers to the stress joint. The clamp is comprised of a plurality of sections with cylindrical interior surfaces which are tightened together using fasteners. The cylindrical interior surfaces avoid damage to the insulation layer which may be elastomeric. The clamp and each centralizer have radially directed projections thereon which interlock the clamp with each centralizer. Because the clamp is axially affixed, the centralizer is then also axially affixed. In one embodiment, the centralizer is axially moveable to a desired axial position prior to being interlocked to the tightened clamp.Type: ApplicationFiled: October 20, 2003Publication date: April 21, 2005Inventors: Carl Baxter, Christopher Caldwell, Robert Rose, Brent Dyer, Michael Beard, Roy Avery
-
Publication number: 20050084337Abstract: A centralizer system is provided for use in a marine riser system to provide a stress joint or keel joint with a upset portion. The centralizer is preferably heat-shrink fitted to the upset portion of the keel joint. The upset portion has tapered sections on the upper and lower ends which may be of various shapes and lengths that gradually blend into the outer diameter of the pipe used as the keel joint. The centralizer may also be heat-shrink fitted to one of the tapered sections. The centralizer may or may not utilize guide sections mounted on either end thereof. In a preferred embodiment, the centralizer comprises axially extending annular grooves in surrounding relationship to the upset portion, the grooves serving to permit forces acting on the centralizer to be redirected or dissipated to thereby prevent excessive buildup on a selected region of the upset portion adjacent the radial grooves.Type: ApplicationFiled: October 20, 2003Publication date: April 21, 2005Inventors: Christopher Caldwell, Carl Baxter, Robert Rose, Brent Dyer, Michael Beard